Antioxidative effects of lovastatin in cultured human endothelial cells

Journal of Nutritional Biochemistry

Volumn 13, Issue 4, 2002, Pages 200-208

  Zhou, Qi ^a   Kummerow, Fred A ^a,b  

^a Harlan E Moore Heart Research Foundation   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

cholesterol; Endothelial cells; Glutathione peroxidase; H2O2 consumption; Lovastatin

Indexed keywords

ACETIC ACID; ANTILIPEMIC AGENT; CHOLESTEROL; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; MEVINOLIN; TRITIUM;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL CULTURE; CHOLESTEROL ESTERIFICATION; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; SERUM;

EID: 0036229188     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-2863(01)00213-3     Document Type: Article

References (46)

1. An excess concentration of oxysterols in the plasma is cytotoxic to cultured endothelial cells
2. The relationship of oxidized lipids to coronary artery stenosis
3. Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic risk
4. Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N′-diphenyl-phenylenediamine
5. The yin and yang of oxidation in the development of the fatty streak
6. Oxidants and antioxidants in the pathogenesis of atherosclerosis; implications for the oxidized low density lipoprotein hypothesis
7. Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation
8. Elevated plasma lipid hydroperoxides in patients with coronary artery disease
9. Clinical predictors of oxidized low-density lipoprotein in patients with coronary artery disease
10. Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease
11. Angiotoxicity and arteriosclerosis due to contaminants of USP-grade cholesterol
12. Toxicity of enzymically-oxidized low-density lipoprotein
13. Cytotoxicity and atherogenicity of oxidized cholesterol
14. Cytotoxicity of oxidation derivatives on cultured aortic smooth muscle cells and their effect on cholesterol biosynthesis
15. Garlic compounds protect vascular endothelial cells from oxidized low density lipoprotein-induced injury
16. Oxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro
17. A delayed and sustained rise of cytosolic calcium is elicited by oxidized LDL in cultured bovine aortic endothelial cells
18. Lipoproteins and inflammation in atherosclerosis
19. Relationship between serum lipid peroxidation products in hypercholesterolaemic subjects and vitamin E status
20. Vitamin E protects against impairment of endothelium-mediated relaxations in cholesterol-fed rabbits
21. Effect of vitamin E on acute iron load-potentated aggregation, serotonin, calcium uptake and thromboxane biosynthesis in rat platelets
22. Lipid peroxidation and endothelial cell injury; implications in atherosclerosis
23. Oxidants and human disease; some new concepts
24. The oxidation of cholesterol
25. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-rapping antioxidant activity of human blood plasma
26. Antioxidant properties of the proteins ceruloplasmin, albumin and transferrin. A study of their activity in serum and synovial fluid from patients with rheumatoid arthritis
27. Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine
28. Antioxidant effects of lovastatin and vitamin E on experimental atherosclerosis in rabbits
29. Hypolipidemic drugs reduce lipoprotein susceptibility to undergo lipid peroxidation; in vitro and ex vivo studies
30. Lipid peroxides in blood from patients with atherosclerosis of coronary and peripheral arteries
31. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions
32. ++ uptake and lipid content in cultured human arterial smooth muscle cells treated with 26-hydroxycholesterol
33. Influence of low magnesium concentrations in the medium on the antioxidant system in cultured human arterial endothelial cells
34. Antioxidant defense mechanisms of endothelial cells; glutathione redox cycle versus catalase
35. Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein
36. Lovastatin and nitrate therapy induced changes in hemorheological parameters and in free radical mediated processes in patients
37. Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages
38. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids
39. Biochemistry of oxygen and nitrogen metabolites
40. Lipid peroxidation, protein thiol oxidation and DNA damage in hydrogen peroxide-induced injury to endothelial cells; Role of activation of poly(ADP-ribose) polymerase
41. 2+ sequestration by the plasma membrane fraction from rat liver
42. Hyperoxia reduces plasma membrane fluidity; A mechanism for endothelial cells dysfunction
43. Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor
44. Tissue-selective acute effects of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase on cholesterol biosynthesis in lens
45. Different effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors on sterol synthesis in various human cell types
46. Inhibition of protein synthesis in baby-hamster kidney cells blocks oxysterol-mediated suppression of 3-hydroxy-3-methylglutaryl-CoA reductase messenger RNA at a post-transcriptional levels